Eastland Julia Marie
- SEC CIK
- 0001500189
In the past year, 1 open-market sale filing worth $21.2K and no purchases.
Current role at each company
- LNTH Lantheus Holdings, Inc.Directoras of May 18, 2026
- ZNTL Zentalis Pharmaceuticals, Inc.CEO & Presidentas of Feb 10, 2026
- DVAX Dynavax Technologies CorpDirectoras of May 28, 2024
- HARP Harpoon Therapeutics, Inc.President and CEOas of Mar 11, 2024
- CALC CalciMedica, Inc.Directoras of Mar 27, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $21.2K
- 1 filing
- Net
- −$21.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Eastland Julia Marie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ZNTL Zentalis Pharmaceuticals, Inc.
CEO & President2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 (view filing) | Feb 6-9 | 4 days | Eastland Julia MarieCEO & President | SSale | −8.76K | $2.43 | −$21.2K | −10.0%79.1K after | 2 lots |
| Feb 4, 2025 (view filing) | Jan 31 | 4 days | Eastland Julia MarieCEO & President | PPurchase | +28.5K | $1.73 | +$49.3K | New position28.5K after |